Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

602
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
602
Disorders of Hemostasis01:24

Disorders of Hemostasis

690
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
690
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

3.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyruvate kinase M2 and Serine Dehydratase are Upregulated in the Macrophages of Human Aortic Atherosclerotic Lesions via Inflammatory Stimuli.

Journal of atherosclerosis and thrombosis·2026
Same author

Dirac-Like Ferrimagnet Ce<sub>3</sub>Au<sub>4</sub>Ge<sub>2</sub>Bi<sub>4</sub> as a Member of a Homologous Series of Square-Net Topological Materials.

Journal of the American Chemical Society·2026
Same author

Synergistic and Selective Antiproliferative Effects of Cafestol and a Hyaluronic Acid-Epigallocatechin Gallate Conjugate in Human Renal Cancer Cells.

International journal of molecular sciences·2026
Same author

Altered motor awareness in Parkinson's disease with progressive micrographia.

Neuropsychologia·2026
Same author

Low-Temperature Plasma-Enhanced Atomic Layer Deposition of Cu Films Using Liquid Copper Precursor Bis(1-ethylmethylamino-2-propoxy)copper, Cu(emap)<sub>2</sub>.

ACS omega·2026
Same author

Cathepsin G is associated with cerebral vascular injury in myeloid leukemia: a pathologic insight into intracranial hemorrhage.

Research and practice in thrombosis and haemostasis·2026

Related Experiment Video

Updated: May 30, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.4K

Histological differences among thrombi in thrombotic diseases.

Atsushi Yamashita1, Toshihiro Gi1, Yuichiro Sato2

  • 1Department of Pathology, Division of Pathophysiology.

Current Opinion in Hematology
|January 28, 2025
PubMed
Summary

Histological analysis reveals distinct thrombus compositions across various conditions, including acute myocardial infarction, stroke, and venous thromboembolism. Understanding these differences is crucial for targeted therapeutic strategies.

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.8K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.7K

Related Experiment Videos

Last Updated: May 30, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.4K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.8K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.7K

Area of Science:

  • Cardiovascular Pathology
  • Thrombosis Research
  • Histopathology

Background:

  • Thrombus formation is a complex process with varying histological characteristics depending on the underlying cause.
  • Differentiating thrombi in conditions like myocardial infarction, stroke, venous thromboembolism, and amniotic fluid embolism is essential for accurate diagnosis and treatment.
  • Recent advancements highlight amniotic fluid embolism as a significant thrombotic event.

Purpose of the Study:

  • To review and compare the histological features of thrombi in acute myocardial infarction, ischemic stroke, venous thromboembolism, and amniotic fluid embolism.
  • To elucidate the unique cellular and molecular compositions of thrombi in different pathological states.
  • To provide a comprehensive overview of current knowledge on thrombosis histology.

Main Methods:

  • Histological examination of thrombi from patients with acute myocardial infarction, ischemic stroke, deep vein thrombosis, and amniotic fluid embolism.
  • Analysis of key components such as platelets, fibrin, von Willebrand factor, collagen, and cancer cells.
  • Review of existing literature and pathological studies on thrombosis.

Main Results:

  • Acute coronary thrombi are small, rich in platelets and fibrin, and lack collagen at rupture sites.
  • Deep vein thrombi are large with time-dependent histological changes; cancer-associated thrombi contain invasive cancer cells.
  • Ischemic stroke thrombi composition varies, but cancer-associated strokes show platelet and fibrin enrichment.
  • Amniotic fluid embolism involves uterine vein thrombi and lung microthrombi.

Conclusions:

  • Atherothrombi form rapidly due to plaque disruption.
  • Venous thrombi develop chronically and can be large.
  • Cancer cells actively contribute to venous thrombosis.
  • Thrombosis in amniotic fluid embolism may lead to coagulopathy and collapse.